Achieving clinical remission for your female patients of childbearing age (aged 18–45)
Dr Anna Moltó is an attending rheumatologist in the Rheumatology Department of Cochin Hospital, Paris, France, and also acts as a clinical researcher in the INSERM ECAMO team (U-1153) from the University of Paris, France.
She completed both her medical studies and rheumatology training at Universitat Autónoma de Barcelona, Spain, in 2010. She completed a clinical research fellowship in Paris, and in 2011, was an assistant professor at Cochin Hospital. Dr Moltó was co-opted by Emerging EULAR Network (EMEUNET) in 2010, where she first served as part of the Country Liaisons subgroup, subsequently as its leader. She was elected Chair of EMEUNET in 2015.
Dr Moltó’s research focuses mainly on the natural history of early axial spondyloarthritis, evaluation of effectiveness in observational trials and pregnancy outcomes in patients with inflammatory rheumatic diseases. She has authored more than 100 peer-reviewed publications.
Join Dr Lykke Midtbøll Ørnbjerg as she explores the value of registry data for informing clinical practice in axSpA.
Watch Dr Floris van Gaalen explore whether early diagnosis of axSpA is possible, drawing on findings from the SPACE cohort.1
Achieving clinical remission for your female patients of childbearing age (aged 18–45)
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...
ASDAS and BASDAI are commonly used in clinical practice.1,2 However, discover recent studies demonstrating that a high proportion of real-world patients do not...